Xcout Intel
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. is a biotechnology research company based in Cambridge, Massachusetts, focused on developing next-generation targeted radiotherapies and combination therapies to treat cancer.
Subscribe to see Convergent Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Convergent Therapeutics, Inc. at a glance
Convergent Therapeutics, Inc. is a biopharmaceutical company headquartered in United States. Its most recent funding round, Series A, raised $40M in September 2024. Xcout tracks 9 named people at Convergent Therapeutics, Inc., including Alex Brown (Chief Operating Officer).
Convergent Therapeutics, Inc. leadership
- Alex BrownChief Operating Officer
- Eric M. SullivanChief Financial Officer
- Andrew DavisChief Business and Strategy Officer
- Elizabeth L. MontgomeryChief People Officer
- Dr. Philip KantoffChief Executive Officer, Co-Founder
- Dr. Neil BanderSenior Scientific Advisor, Co-Founder
3 more named people on record for Convergent Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Convergent Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | 4 named | |
| SEC Form D filing | $22.2M | — | |
| SEC Form D filing | $29.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Convergent Therapeutics, Inc. competitors
A few of Convergent Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Fusion Pharmaceuticals is a pharmaceutical company focused on developing targeted radiopharmaceuticals for the treatment of cancer patients.
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for oncology and is based in Toronto, Canada, with a corporate office in Boston, Massachusetts.
Cognito Therapeutics Ltd. is a clinical-stage company headquartered in Cambridge, Massachusetts, that has conducted multiple clinical studies for its therapeutic products.
Citius Oncology is a biopharmaceutical company that develops and commercializes targeted oncology therapies. It serves patients with cancer, including its FDA-approved targeted immune therapy LYMPHIR for cutaneous T-cell lymphoma.
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Get Convergent Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Convergent Therapeutics, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access